The Role of New Quinolones in the Treatment of Respiratory Tract Infections
- 1 January 1995
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 49 (Supplement) , 144-151
- https://doi.org/10.2165/00003495-199500492-00024
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Structure-activity and structure-side-effect relationships for the quinolone antibacterialsJournal of Antimicrobial Chemotherapy, 1994
- Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study GroupAntimicrobial Agents and Chemotherapy, 1994
- Antimicrobial Treatment of Community Acquired Pneumonia in Adults: A Conference ReportCanadian Journal of Infectious Diseases and Medical Microbiology, 1993
- Initial Antimicrobial Treatment of Hospital Acquired Pneumonia in Adults: A Conference ReportCanadian Journal of Infectious Diseases and Medical Microbiology, 1993
- The Withdrawal of TemafloxacinDrug Safety, 1993
- Predicting Death in Patients Hospitalized for Community-acquired PneumoniaAnnals of Internal Medicine, 1991
- Infectious Complications with Respiratory Pathogens despite Ciprofloxacin TherapyNew England Journal of Medicine, 1991
- Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumoniaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service.1987
- PROSPECTIVE STUDY OF THE AETIOLOGY AND OUTCOME OF PNEUMONIA IN THE COMMUNITYThe Lancet, 1987